Researcher
Bart Keymeulen
- Research Expertise:
Full professor of Medicine - Vrije Universiteit Brussel
Head Diabetes Clinic & Clinical Trial Center - UZ Brussel
Head Research Cluster Diabetes - Vrije Universiteit Brussel
Head Diabetes Biobank associated with Belgian Diabetes Registry
- Keywords:Medicine
- Disciplines:Endocrinology and metabolic diseases not elsewhere classified, Immunology not elsewhere classified
- Users of research expertise:
Full professor of Medicine - Vrije Universiteit Brussel
Head Diabetes Clinic & Clinical Trial Center - UZ Brussel
Head Research Cluster Diabetes - Vrije Universiteit Brussel
Head Diabetes Biobank associated with Belgian Diabetes Registry
Affiliations
- Diabetes Pathology & Therapy (Research group)
Responsible
From2 Feb 2011 → Today - Diabetes Clinic (Department)
Member
From1 Jan 2008 → Today - Clinical sciences (Department)
Member
From1 Oct 2023 → Today - Pathology/molecular and cellular medicine (Department)
Member
From1 Oct 2019 → Today - Pathology/molecular and cellular medicine (Department)
Member
From8 Apr 2019 → 30 Sep 2023 - Pathology/molecular and cellular medicine (Department)
Responsible
From1 Jan 2014 → 20 Oct 2022 - Pathology/molecular and cellular medicine (Department)
Member
From1 Jan 2014 → 30 Sep 2016 - Internal Medicine Specializations (Department)
Member
From1 Apr 1997 → 31 Dec 2013 - Pathologic Biochemistry and Physiology (Department)
Member
From1 Oct 1989 → 31 Dec 2013
Projects
1 - 4 of 4
- Hilde Bruers prijs 2022From12 May 2022 → TodayFunding: Universities as sponsor
- Predicting impending beta cell loss and dysglycemia in asymptomatic type 1 diabetes - Validation of minimally invasive markers against the hyperglycemic clamp test.From1 Nov 2021 → TodayFunding: FWO fellowships
- SRP (Groeiers): Biomarkers for staging diabetes and guiding its prevention and treatmentFrom1 Mar 2014 → 28 Feb 2019Funding: BOF - Concerted Research Project from 1994
- BetaCellTherapy : Beta Cell Therapy in Diabetes.From1 Jan 2010 → 30 Jun 2015Funding: Health
Publications
1 - 10 of 55
- Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetes(2023)
Authors: Aster K Desouter, Bart Keymeulen, Simke Demeester, Pieter De Pauw, A Van Dalem, Bruno Lapauw, Christophe De Block, Pieter Gillard, Danny Pipeleers, Frans K Gorus
- Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes(2023)
Authors: Valeria Sordi, Paolo Monti, Vito Lampasona, Raffaella Melzi, Silvia Pellegrini, Bart Keymeulen, Pieter Gillard, Thomas Linn, Emanuele Bosi, Ludger Rose, et al.
- First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes(2023)
Authors: Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie, Mohammad Alhadj Ali, Colin Dayan, Bart Keymeulen, Katharine R Owen, Martin Kindermans, Frédéric Parmentier, Vincent Carlier, et al.
- CTLA4, SH2B3 and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of type 1 diabetes patients(2023)
Authors: Julie Vandewalle, Aster K Desouter, Bart J Van der Auwera, Sylvie Tenoutasse, Pieter Gillard, Christophe De Block, Bart Keymeulen, Frans K Gorus, Mark Van De Casteele
Pages: 224-232 - Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes(2023)
Authors: Margaretha M Visser, Sara Charleer, Steffen Fieuws, Christophe De Block, Robert Hilbrands, Liesbeth Van Huffel, Toon Maes, Gerd Vanhaverbeke, Eveline Dirinck, Nele Myngheer, et al.
Pages: 96-108 - Comparison of Omentum and Subcutis as Implant Sites for Device-Encapsulated Human iPSC-Derived Pancreatic Endoderm in Nude Rats(2023)
Authors: Jolien R Nijns, Ines De Mesmaeker, Krista G Suenens, Geert M Stangé, Kaat De Groot, Maria Marques de Lima, Marine R C Kraus, Bart Keymeulen, Wim Waelput, Daniel Jacobs-Tulleneers-Thevissen, et al.
- Ladarixin, an inhibitor of IL-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes(2022)
Authors: Lorenzo Piemonti, Bart Keymeulen, Pieter Gillard, Thomas Linn, Emanuele Bosi, Ludger Rose, Paolo Pozzilli, Francesco Giorgino, Efisio Cossu, Luisa Daffonchio, et al.
Pages: 1840-1849 - Utility of islet cell preparations from donor pancreases after euthanasia(2022)
Authors: Diedert L De Paep, Freya Van Hulle, Zhidong Ling, Marian Vanhoeij, Robert Hilbrands, Wim Distelmans, Pieter Gillard, Bart Keymeulen, Daniel Pipeleers, Daniel Jacobs-Tulleneers-Thevissen
Pages: 9636897221096160 - Relationship between time in range, glycemic variability, HbA1c and complications in adults with type 1 diabetes mellitus(2022)
Authors: Anass El Malahi, Michiel Van Elsen, Sara Charleer, Eveline Dirinck, Kristien J. Ledeganck, Bart Keymeulen, Laurent Crenier, Régis P Radermecker, Youri Taes, Chris Vercammen, et al.
Pages: e570-e581 - Lipohypertrophy Monitoring Study (LIMO)(2022)
Authors: Niels Bochanen, Katelijn Decochez, Els Heleu, Joke Cuypers, Chris Vercammen, Peter Coremans, Gerd Vanhaverbeke, Samyah Shadid, Bart Keymeulen, Nancy Bolsens, et al.